Ernest Pharmaceuticals
PrivateLast Round
Grant
Mar 7, 2024
Total Funding Raised
$1.55M
Company Overview
Ernest Pharmaceuticals is a biotechnology company that develops bacterial therapeutics for the treatment of solid tumors through intracellular macromolecule delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ernest Pharmaceuticals Comparables
Compare Ernest Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Laguna Bio | 82% | |
| Neobe Therapeutics | 82% | |
| Actym Therapeutics | 81% | |
Ernest Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 7, 2024 | ||||
| Accelerator | Mar 16, 2022 | ||||
| Grant | Jan 15, 2021 | ||||
| Grant | Sep 15, 2020 | ||||
| Grant | Sep 13, 2019 | ||||
Grant | Sep 9, 2018 |
Ernest Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| The Termeer Institute | Accelerator |
| Massachusetts Life Sciences Center | Grant |
| National Institutes of Health (NIH) | Grant |
| Lever | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors grew 641% MoM, from 200 to 1.5K.
- Jan 7, 2026
Monthly visitors increased 124% MoM.
Ernest Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ernest Pharmaceuticals's valuation, stock price, and market status.